Atlas Trials

The Clinical Trial to Evaluate the Pharmacokinetics, Safety and Tolerability of ZL-2306 (Niraparib) in Patients With Ovarian Cancer

Clinical trial NCT03551171 · COMPLETED

Trial details

NCT number
NCT03551171
Sponsor
Zai Lab (Shanghai) Co., Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Ovarian Cancer
Start date
2017-12-19
Primary completion
2018-05-03
Enrollment
42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.